How SARS-CoV-2 evades the immune system

Researchers in Japan and the United States have found SARS-CoV-2 can knock out an important molecular pathway linked to an immune complex called MHC class I. The finding should help scientists better understand how COVID-19 infection takes hold.

Viruses, Free Full-Text

Proteolytic cleavage of nucleocapsid helps SARS-CoV-2 evade host immune responses

Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections

Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies - ScienceDirect

Viruses, Free Full-Text

The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity, Virology Journal

Inflammatory pathways and potential therapies for COVID-19: A mini review - Areeg M Dabbish, Nouran Yonis, Mohamed Salama, Musthafa M Essa, M Walid Qoronfleh, 2021

Alpha Coronavirus Variant Evolved to Evade Immune System

B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination - ScienceDirect

SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells

Why Viruses Like SARS-CoV-2 Can Reinfect Us, Evade Immune Response - Harvard Catalyst

COVID-19, Predicted Immune responses